These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2049813)

  • 21. Synthesis and biological activities of optical isomers of 2-(4-diphenylmethyl-1-piperazinyl)ethyl 5-(4,6-dimethyl-2-oxo-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dim ethyl-4-(3-nitrophenyl)-3-pyridinecarboxylate dihydrochloride (NIP-101).
    Sakoda R; Kamikawaji Y; Seto K
    Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2370-6. PubMed ID: 1446357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and antihypertensive activities of new 1,4-dihydropyridine derivatives containing nitrooxyalkylester moieties at the 3- and 5-positions.
    Ogawa T; Nakazato A; Tsuchida K; Hatayama K
    Chem Pharm Bull (Tokyo); 1993 Jun; 41(6):1049-54. PubMed ID: 8370105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and biological activities of new 2-substituted 1,4-benzoxazine derivatives.
    Kajino M; Shibouta Y; Nishikawa K; Meguro K
    Chem Pharm Bull (Tokyo); 1991 Nov; 39(11):2896-905. PubMed ID: 1799938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and biological activity of novel calcium channel blockers: 2,5-dihydro-4-methyl-2-phenyl-1,5-benzothiazepine-3-carboxylic acid esters and 2,5-dihydro-4-methyl-2-phenyl-1,5-benzodiazepine-3-carboxylic acid esters.
    Atwal KS; Bergey JL; Hedberg A; Moreland S
    J Med Chem; 1987 Apr; 30(4):635-40. PubMed ID: 2435903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, calcium-channel-blocking activity, and antihypertensive activity of 4-(diarylmethyl)-1-[3-(aryloxy)propyl]piperidines and structurally related compounds.
    Shanklin JR; Johnson CP; Proakis AG; Barrett RJ
    J Med Chem; 1991 Oct; 34(10):3011-22. PubMed ID: 1920352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and calcium channel antagonist activity of 1,4-dihydropyridine derivatives containing 4-nitroimidazolyl substituents.
    Shafiee A; Rastkary N; Jorjani M
    Arzneimittelforschung; 2002; 52(7):537-42. PubMed ID: 12189777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-activity relationships of 4-(phenylethynyl)-6-phenyl-1,4-dihydropyridines as highly selective A3 adenosine receptor antagonists.
    Jiang J; van Rhee AM; Chang L; Patchornik A; Ji XD; Evans P; Melman N; Jacobson KA
    J Med Chem; 1997 Aug; 40(16):2596-608. PubMed ID: 9258367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antihypertensive effect of NKY-722, a new water-soluble 1,4-dihydropyridine derivative, on conscious spontaneously hypertensive rats.
    Osumi S; Morishita S; Wada K; Usui H; Kanda M; Matsui H; Kakeya N
    Tohoku J Exp Med; 1988 Jun; 155(2):205-6. PubMed ID: 3212781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and antihypertensive activities of 1,4-dihydropyridine-5-phosphonate derivatives. II.
    Morita I; Kunimoto K; Tsuda M; Tada S; Kise M; Kimura K
    Chem Pharm Bull (Tokyo); 1987 Oct; 35(10):4144-54. PubMed ID: 3435941
    [No Abstract]   [Full Text] [Related]  

  • 30. Synthesis and smooth muscle calcium channel effects of dialkyl 1,4-dihydro-2,6-dimethyl-4-aryl-3,5-pyridinedicarboxylates containing a nitrone moiety in the 4-aryl substituent.
    Anana RD; Ng H; Howlett SE; Knaus EE
    Arch Pharm (Weinheim); 1997 Mar; 330(3):53-8. PubMed ID: 9167447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on nilvadipine. I. Synthesis and structure-activity relationships of 1,4-dihydropyridines containing novel substituents at the 2-position.
    Satoh Y; Ichihashi M; Okumura K
    Chem Pharm Bull (Tokyo); 1991 Dec; 39(12):3189-201. PubMed ID: 1814611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of the novel water-soluble calcium antagonist (+/-)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride on the responses of isolated canine arteries.
    Kanda M; Shirahase H; Kurahashi K; Wada K; Nakamura S; Matsui H; Fukata F
    Arzneimittelforschung; 1995 Aug; 45(8):831-5. PubMed ID: 7575741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of expected metabolites of benidipine hydrochloride.
    Muto K; Kuroda T; Kawato H; Nishikawa H; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1666-70. PubMed ID: 3219138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and X-ray crystal structure of the calcium channel antagonist: dimethyl 1,4-dihydro-2,6-dimethyl-4-[4'-(4H-4-oxo-1-benzopyran-2-yl)phenyl]- 3,5-pyridine dicarboxylate.
    Tunçbilek M; Ozbey S; Kendi E; Yildirim E; Erol K; Ertan R
    Farmaco; 1999 Oct; 54(10):660-5. PubMed ID: 10575734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular activities of the new potent and long-lasting antihypertensive calcium entry blocker (+-)-3-ethyl,5-methyl,2- ([2-(formylamino)-ethyl]- thiomethyl)-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicar box ylate.
    Germini M; Passoni A; Casciarri I; Bosetti P; Piazzoni L; Cazzulani P; Gandolfi CA; Tofanetti O; Ceserani R
    Arzneimittelforschung; 1992 Jan; 42(1):1-8. PubMed ID: 1586373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dihydropyrimidine calcium channel blockers. 4. Basic 3-substituted-4-aryl-1,4-dihydropyrimidine-5-carboxylic acid esters. Potent antihypertensive agents.
    Rovnyak GC; Atwal KS; Hedberg A; Kimball SD; Moreland S; Gougoutas JZ; O'Reilly BC; Schwartz J; Malley MF
    J Med Chem; 1992 Aug; 35(17):3254-63. PubMed ID: 1387168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dihydropyrimidine calcium channel blockers: 2-heterosubstituted 4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridines.
    Atwal KS; Rovnyak GC; Schwartz J; Moreland S; Hedberg A; Gougoutas JZ; Malley MF; Floyd DM
    J Med Chem; 1990 May; 33(5):1510-5. PubMed ID: 2329573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and calcium channel-modulating effects of alkyl (or cycloalkyl) 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridyl-5-pyridinecarboxylate racemates and enantiomers.
    Ramesh M; Matowe WC; Akula MR; Vo D; Dagnino L; Li-Kwong-Ken MC; Wolowyk MW; Knaus EE
    J Med Chem; 1998 Feb; 41(4):509-14. PubMed ID: 9484501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 3rd communication: antihypertensive effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3-b] pyridine-5-carboxylate in hypertensive rats and dogs.
    Ueda M; Matsumura S; Masui M; Matsuura E; Kawakami M; Fujitomo H; Umeda T; Kagawa H; Hirohata S; Shima K
    Arzneimittelforschung; 1993 Dec; 43(12):1282-90. PubMed ID: 8141815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and calcium channel antagonist activity of dialkyl 1,4-dihydro-2,6-dimethyl-4-[3-(1-methoxy-carbonyl-4-substituted-1,4- dihydro-pyridyl)]-3,5-pyridinedicarboxylates.
    Ramesh M; Matowe WC; Knaus EE; Wolowyk MW
    Drug Des Discov; 1992 Jul; 8(4):313-23. PubMed ID: 1445996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.